Purpose of Screening
- Early diagnosis of Spinal Muscular Atrophy (SMA).
- Identifying the exact genetic cause of motor delay and weakness.
- Enabling medical teams to initiate early gene therapy plans.
Book SMA Genetic Test in Saudi Arabia | Lahalak Medical Platform
A precision genetic test to detect SMN1 gene mutations causing Spinal Muscular Atrophy in infants. Early screening facilitates rapid intervention, preventing motor deterioration and ensuring a healthier developmental future.
Scientific name: Genetic Screening for Spinal Muscular Atrophy (SMA)
An advanced molecular laboratory test designed to detect deletions or mutations in the SMN1 gene. Recommended for infants showing muscle weakness or motor delays to ensure accurate diagnosis and treatment.
Service type
Genetic Laboratory Test
Duration
15-20 minutes
Fasting
Fasting is not required
Included Services
- Blood sample collection
- SMN1 gene molecular analysis
- Detailed medical report
Medical Service Information
Target Groups
- Infants presenting with proximal muscle weakness.
- Children showing significant delays in standing or walking milestones.
- Families with a known history of genetic motor disorders.
Importance of Early Diagnosis
- Improving child responsiveness to modern therapies.
- Minimizing the degradation of motor neurons.
- Providing appropriate supportive care at the earliest stage.
Conditions & Notices
- Previous medical reports preferred
- No fasting required
Medical services you might also like
